Viewing Study NCT04405505


Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-02-22 @ 2:53 AM
Study NCT ID: NCT04405505
Status: UNKNOWN
Last Update Posted: 2020-05-28
First Post: 2020-05-24
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule Versus Paclitaxel for Injection (Albumin Bound) in Subjects With Triple Negative Breast Cancer (TNBC)
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module